Locally Advanced or Metastatic Unresectable Urothelial Cancer research hub

Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer

This study compares a new medicine called Sacituzumab Govitecan with standard treatments for advanced bladder cancer that has spread or can't be removed. Researchers want to see if the new medicine helps people live longer and feel better.